Thursday, March 21, 2019 5:16:16 PM
One case frequently referenced is the FDAs legal action against Regenerative Sciences, LLC. Information can be found here D.C. Circuit Rules That FDA Can Regulate Autologous Stem Cells
Note: Regenerative mixed bono marrow, blood, cultured stem cells and doxycycline (antibiotic). This product mixture is materially different than USRM’s adipose stem cell, which isn't a mixture, as a patient's own stem cells are exclusively what's injected into their body.
So, will the Federal Court see the differentce between Regenerativbe's mixture and USRM's sole tissue? I hope so.
Interesting to note that Regenerative, having lost the case, is still actively in business. Here is a note appearing on their website to explain their business
In conclusion, if USRM loses to the FDA, there is a strong precedent that USRM could remain actively engaged in Stem Cell research development and treatment.
My post are for entertainment purpose only
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM